Nobel Prize to HPV Researcher Highlights Importance of Cervical Cancer Screening and Prevention...

Monday October 6, 4:21 pm ET QIAGEN's HPV testing technologies are a successful commercialization of the Nobel Prize in Medicine winner's research VENLO, Netherlands, Oct. 6 /PRNewswire/ -- The Nobel Prize-winning discovery of the causal link between human papillomavirus (HPV) and cervical cancer has spurred lifesaving prevention technologies -- such as HPV testing and HPV vaccines -- that are helping to eradicate cervical cancer globally. The Nobel Prize Committee today announced that Professor Harald zur Hausen at the German Cancer Research Center in Heidelberg will receive this year's Nobel Prize in Medicine/Physiology for the discovery of certain human papillomaviruses (HPV) as the primary cause of cervical cancer. Expanding on Prof. zur Hausen's research, QIAGEN (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) developed... [read full story]